carvedilol has been researched along with transforming growth factor beta in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (55.56) | 29.6817 |
| 2010's | 2 (22.22) | 24.3611 |
| 2020's | 2 (22.22) | 2.80 |
| Authors | Studies |
|---|---|
| Chambers, TM; Dong, Q; Holland, RE; Lin, C; Lu, Z; Zimmer, SG | 1 |
| Barone, F; Brooks, DP; Campbell, WG; Contino, LC; Gygielko, E; Laping, NJ; Nelson, AH; Olson, BA; Wong, VY | 1 |
| Antonello, A; Calò, L; Davis, PA; Giacon, B; Huber, W; Pagnin, E; Piccin, A; Riegler, P; Semplicini, A | 1 |
| Cheng, X; Ge, H; Guo, H; Li, B; Liao, YH; Wang, M | 1 |
| Chang, H; Lu, MJ; Shyu, KG; Sun, HY; Wang, BW | 1 |
| Campos-Esparza, Mdel R; Cervantes-García, D; Elías-Flores, TG; Gerardo-Rodríguez, M; Llamas-Ramírez, RW; Muñoz-Fernández, L; Muñoz-Ortega, MH; Romero-Delgadillo, NI; Tavares-Rodríguez, Ede J; Ventura-Juárez, J | 1 |
| Berg, G; Bertera, FM; Carranza, A; Chiappetta, DA; Del Mauro, JS; Donato, M; Fernandez Machulsky, N; Gelpi, RJ; González, GE; Gorzalczany, SB; Höcht, C; Morales, C; Morettón, MA; Prince, PD; Taira, CA | 1 |
| Abu-Risha, SE; Akool, ES; Alkabbani, MA; Sokar, SS | 1 |
| Abbas, NAT; Abdelmageed, AF; Afifi, R; Hassan, HA; Mohammed, HO; Nafea, OE; Samy, W | 1 |
1 trial(s) available for carvedilol and transforming growth factor beta
| Article | Year |
|---|---|
Oxidative stress and TGFbeta in kidney-transplanted patients with cyclosporin-induced hypertension. Effect of carvedilol and nifedipine.
Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Carbazoles; Carvedilol; Cyclosporine; Drug Evaluation; Female; Heme Oxygenase (Decyclizing); Heme Oxygenase-1; Humans; Hypertension; Immunosuppressive Agents; Kidney Transplantation; Male; Membrane Proteins; Middle Aged; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Oxidative Stress; Postoperative Complications; Propanolamines; RNA, Messenger; Signal Transduction; Transforming Growth Factor beta; Treatment Outcome; Tyrosine | 2002 |
8 other study(ies) available for carvedilol and transforming growth factor beta
| Article | Year |
|---|---|
The involvement of a stress-activated pathway in equine influenza virus-mediated apoptosis.
Topics: Animals; Apoptosis; Carbazoles; Carvedilol; Cell Line; Cytopathogenic Effect, Viral; DNA Fragmentation; Dogs; Enzyme Activation; In Situ Nick-End Labeling; Influenza A virus; Mitogen-Activated Protein Kinase 8; Mitogen-Activated Protein Kinases; Oligodeoxyribonucleotides, Antisense; Orthomyxoviridae Infections; Oxidative Stress; Propanolamines; Signal Transduction; Transforming Growth Factor beta; Virus Replication | 2001 |
Renoprotective effects of carvedilol in hypertensive-stroke prone rats may involve inhibition of TGF beta expression.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Carbazoles; Carvedilol; Collagen Type I; Dietary Fats; Female; Fibronectins; Fibrosis; Gene Expression Regulation; Heart Rate; Hypertension; Kidney; Male; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; RNA, Messenger; Severity of Illness Index; Sodium Chloride, Dietary; Transforming Growth Factor beta | 2001 |
Effects of carvedilol on cardiac cytokines expression and remodeling in rat with acute myocardial infarction.
Topics: Animals; Carbazoles; Carvedilol; Cytokines; Disease Models, Animal; Heart; Interleukin-10; Interleukin-1beta; Interleukin-6; Male; Myocardial Infarction; Propanolamines; Rats; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha; Vasodilator Agents | 2006 |
Myostatin expression in ventricular myocardium in a rat model of volume-overload heart failure.
Topics: Animals; Antihypertensive Agents; Aorta; Blood Pressure; Body Weight; Carbazoles; Carvedilol; Heart; Heart Failure; Heart Rate; Myocardium; Myostatin; Organ Size; Propanolamines; Rats; Rats, Sprague-Dawley; RNA, Messenger; Transforming Growth Factor beta; Venae Cavae | 2006 |
Doxazosin Treatment Attenuates Carbon Tetrachloride-Induced Liver Fibrosis in Hamsters through a Decrease in Transforming Growth Factor β Secretion.
Topics: Adrenergic alpha-1 Receptor Antagonists; Alanine Transaminase; Animals; Aspartate Aminotransferases; Bilirubin; Carbazoles; Carbon Tetrachloride; Carvedilol; Collagen Type I; Cricetinae; Doxazosin; Liver; Liver Cirrhosis; Liver Function Tests; Propanolamines; Serum Albumin; Transforming Growth Factor beta | 2016 |
Effects of carvedilol or amlodipine on target organ damage in L-NAME hypertensive rats: their relationship with blood pressure variability.
Topics: Amlodipine; Animals; Antihypertensive Agents; Aorta; Biomarkers; Blood Pressure; Blood Pressure Determination; Carbazoles; Carvedilol; Collagen; Disease Models, Animal; Fibrosis; Heart Ventricles; Humans; Hypertension; Interleukin-6; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; NG-Nitroarginine Methyl Ester; Propanolamines; Rats; Rats, Wistar; Transforming Growth Factor beta; Tumor Necrosis Factor-alpha | 2017 |
Hepatoprotective effects of carvedilol and crocin against leflunomide-induced liver injury.
Topics: Animals; Carvedilol; Catalase; Chemical and Drug Induced Liver Injury; Chemical and Drug Induced Liver Injury, Chronic; Leflunomide; Liver; Male; Mice; Oxidative Stress; Phosphatidylinositol 3-Kinases; Serum Albumin; TOR Serine-Threonine Kinases; Transforming Growth Factor beta | 2022 |
Repurposing of carvedilol to alleviate bleomycin-induced lung fibrosis in rats: Repressing of TGF-β1/α-SMA/Smad2/3 and STAT3 gene expressions.
Topics: Actins; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Agonists; Animals; Bleomycin; Carvedilol; Disease Models, Animal; Drug Repositioning; Gene Expression; Idiopathic Pulmonary Fibrosis; Male; Rats; Rats, Inbred Strains; Smad2 Protein; Smad3 Protein; STAT3 Transcription Factor; Transforming Growth Factor beta | 2023 |